Innospec, Inc.

Innospec, Inc., a small-cap company in the Chemicals and Petrochemicals sector, has a P/E ratio of 14 and a notable dividend yield of 1051.30%. Its stock price recently closed at $76.26, reflecting a challenging year with a return of -14.77%, compared to the S&P 500's gain of 29.45%.

Innospec, Inc., a small-cap company in the Chemicals and Petrochemicals sector, has adjusted its valuation, showcasing a solid financial position with favorable P/E and price-to-book ratios. The company demonstrates strong operational performance and impressive returns for shareholders, positioning itself well against peers in the industry.

Innospec, Inc. has recently adjusted its valuation metrics, reporting a P/E ratio of 14 and a price-to-book value of 1.52. The company features a notable dividend yield of 1051.30% and a ROCE of 14.89%. Its stock performance has lagged behind the S&P 500 over the past year.

Innospec, Inc., a small-cap company in the Chemicals & Petrochemicals sector, has recently adjusted its valuation. The firm has faced a challenging year with a notable decline in returns. Despite this, it maintains competitive financial metrics, including a high dividend yield and favorable P/E and EV to EBITDA ratios compared to industry peers.

Innospec, Inc. has reached a new 52-week low, reflecting a significant decline in stock performance over the past year. The company, with a market capitalization of USD 2,022 million, shows a high dividend yield and low debt levels, but has faced challenges including decreased net profit and operating cash flow.

Innospec, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, with a market capitalization of USD 2,022 million, faces challenges including a net profit decline and low operating cash flow, despite a high dividend yield.

Innospec, Inc. has reached a new 52-week low, reflecting a challenging year with a significant stock price decline. The company maintains a market capitalization of USD 2,022 million and a high dividend yield. Despite profitability indicators, it faces difficulties with declining net profit and operating cash flow.

Innospec, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, with a market capitalization of USD 2,411 million, faces challenges including a negative growth rate in net profit and low operating cash flow, despite a high dividend yield.

Innospec, Inc., a small-cap company in the Chemicals & Petrochemicals sector, has experienced a challenging year with a significant decline in stock performance compared to the S&P 500. Current technical indicators suggest a bearish sentiment, reflecting the company's struggles in a competitive market environment.

Innospec, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company, with a market capitalization of USD 2,411 million, shows a high dividend yield but struggles with growth, raising concerns about its competitive position in the market.

Innospec, Inc. has recently encountered a technical event known as a Death Cross, indicating a potential shift in market sentiment. Current indicators reflect a bearish outlook, with the stock underperforming significantly over the past year and year-to-date, suggesting ongoing challenges in the market environment.

Innospec, Inc., a small-cap company in the Chemicals & Petrochemicals sector, has experienced a recent price decline. Technical indicators present a mixed outlook, with some suggesting bullish trends while others indicate bearish signals. The company's performance has lagged behind the S&P 500, reflecting ongoing market challenges.

Innospec, Inc., a small-cap company in the Chemicals & Petrochemicals sector, has recently achieved a Golden Cross, indicating a potential shift in momentum. Despite a 25.93% decline over the past year, this technical signal may suggest a possible recovery as the company navigates its market position.

Innospec, Inc., a small-cap company in the Chemicals & Petrochemicals sector, has adjusted its valuation metrics, showcasing a competitive price-to-earnings ratio of 13 and a high dividend yield of 915.95%. Its strong operational performance is reflected in a return on capital employed of 15.96% and return on equity of 13.44%.

Innospec, Inc. reported a mixed financial performance for the quarter ending December 2025, achieving a record dividend and solid operating profit, while facing challenges with declining operating cash flow and net profit. The company's stock has underperformed compared to broader market indices, highlighting operational hurdles.

Innospec, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, with a market capitalization of USD 2,534 million, has a high dividend yield and low debt-to-equity ratio, but has struggled to match market benchmarks.

Innospec, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, with a market capitalization of USD 2,534 million, has a high dividend yield and a conservative financial structure, but faces challenges in profitability and growth.

Innospec, Inc., a small-cap company in the Chemicals & Petrochemicals sector, has recently adjusted its valuation metrics, including a P/E ratio of 14 and a notable dividend yield of 787.74%. Despite competitive financial indicators, the company has underperformed compared to the S&P 500, indicating market challenges.

Innospec, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, with a market capitalization of USD 2,534 million, has a high dividend yield and low debt-to-equity ratio, but has struggled to outperform market benchmarks.